Hill-Rom Holdings Inc. (NYSE:HRC) COO Carlyn D. Solomon sold 40,515 shares of the company’s stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $54.78, for a total transaction of $2,219,411.70. Following the completion of the sale, the chief operating officer now owns 22,163 shares in the company, valued at approximately $1,214,089.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Hill-Rom Holdings Inc. (NYSE:HRC) traded down 0.54% on Friday, hitting $55.45. 553,322 shares of the stock traded hands. Hill-Rom Holdings Inc. has a 52-week low of $42.99 and a 52-week high of $63.12. The stock has a market cap of $3.63 billion, a P/E ratio of 57.11 and a beta of 1.20. The stock’s 50 day moving average price is $58.17 and its 200 day moving average price is $54.54.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Thursday, November 3rd. The medical technology company reported $1.18 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.05. The firm earned $706 million during the quarter, compared to analyst estimates of $701.39 million. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The business’s revenue was up 23.0% on a year-over-year basis. During the same quarter last year, the business earned $0.89 EPS. On average, equities analysts expect that Hill-Rom Holdings Inc. will post $3.78 EPS for the current fiscal year.

Several large investors have recently added to or reduced their stakes in HRC. Parametrica Management Ltd bought a new stake in shares of Hill-Rom Holdings during the second quarter worth $321,000. LS Investment Advisors LLC raised its stake in shares of Hill-Rom Holdings by 67.4% in the second quarter. LS Investment Advisors LLC now owns 3,783 shares of the medical technology company’s stock worth $191,000 after buying an additional 1,523 shares during the last quarter. IBM Retirement Fund raised its stake in shares of Hill-Rom Holdings by 16.4% in the second quarter. IBM Retirement Fund now owns 6,611 shares of the medical technology company’s stock worth $334,000 after buying an additional 931 shares during the last quarter. Copper Rock Capital Partners LLC raised its stake in shares of Hill-Rom Holdings by 1.6% in the second quarter. Copper Rock Capital Partners LLC now owns 589,208 shares of the medical technology company’s stock worth $29,726,000 after buying an additional 9,148 shares during the last quarter. Finally, Nordea Investment Management AB raised its stake in shares of Hill-Rom Holdings by 278.3% in the second quarter. Nordea Investment Management AB now owns 12,670 shares of the medical technology company’s stock worth $639,000 after buying an additional 9,321 shares during the last quarter. Hedge funds and other institutional investors own 81.01% of the company’s stock.

Separately, Zacks Investment Research cut shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Wednesday, October 5th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $62.20.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

5 Day Chart for NYSE:HRC

Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.